Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 79

Sort by

Sort Order Select

Journal Articles

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells

Blood (2019) 134 (Supplement_1): 1947.

https://doi.org/10.1182/blood-2019-126208

Published: 2019

Journal Articles

Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis

Aafke E. Gaartman, MD, Ajab K. Sayedi, BSc, Charlotte F.J. Van Tuijn, MPH, PhD, Harriet Heijboer, MD PhD, Tanja Netelenbos, MD PhD, Bart J. Biemond, MD PhD, Erfan Nur, MD PhD

Blood (2019) 134 (Supplement_1): 1024.

https://doi.org/10.1182/blood-2019-130248

Published: 2019

Journal Articles

Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide

Luke Eastburg, MD, David A. Russler-Germain, MDPhDBS, Ramzi Abboud, MD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD, Michael W. Becker, MD, Neha Kumar, MD, Omar S. Aljitawi, MD, Jeffrey R. Andolina, MD MS, Thomas J Fountaine, MD, Jane L. Liesveld, MD, Eric Huselton, MD

Blood (2019) 134 (Supplement_1): 4496.

https://doi.org/10.1182/blood-2019-129872

Published: 2019

Journal Articles

Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure

Derek Galligan, MD, Rupa Narayan, MD, Sarah Kim, PharmD, Ann Lazar, PhD MS, Marisela Tan, PharmD, Richard Fong, PharmD, Mimi Lo, PharmD, Nina Shah, MD, Shagun Arora, MD, Sandy W. Wong, MD, Thomas G. Martin, III, MD, Jeffrey Lee Wolf, MD

Blood (2018) 132 (Supplement 1): 3236.

https://doi.org/10.1182/blood-2018-99-111625

Published: 2018

Journal Articles

The High Output State of Sickle Cell Patients: Associations with Anemia-Related Organ Damage

Bart J. Biemond, MD PhD, Tim R. de Back, MD, Charlotte F.J. Van Tuijn, MPH, PhD, Erfan Nur, MD PhD, Berto J. Bouma, MD PhD

Blood (2018) 132 (Supplement 1): 3661.

https://doi.org/10.1182/blood-2018-99-117501

Published: 2018

Journal Articles

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Muhammad Aadil Rahman, MD, Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Asad Fraz, MD, Faiza Jamil, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2018-99-115214

Published: 2018

Journal Articles

Long-Term Durable Responses after Autologous Stem Cell Transplantation in POEMS Syndrome

Blood (2018) 132 (Supplement 1): 4606.

https://doi.org/10.1182/blood-2018-99-115710

Published: 2018

Journal Articles

Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis

Sarah S Lee, MD, Nathaniel Rosko, PharmD, Bhumika J. Patel, MD, Madeline Waldron, PharmD, Jackie Tomer, MPH, Roman Goldman, CNP, Mary Ann Karam, RN, Janice Reed, RN, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Saveta Mathur, CNP, Christy J. Samaras, DO, Jason Valent, MD

Blood (2018) 132 (Supplement 1): 2009.

https://doi.org/10.1182/blood-2018-99-119979

Published: 2018

Journal Articles

Weight Increase during Induction Therapy Predicts Intensive Care Unit (ICU) Transfer in Patients (Pts) with Acute Promyelocytic Leukemia (APL)

Kamal Chamoun, MD, Hagop M. Kantarjian, MD, Kiran Naqvi, MD MPH, Xuemei Wang, MS, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Elias J. Jabbour, MD, Tapan M. Kadia, MD, Naval G. Daver, MD, Courtney D. DiNardo, MD MSc, Nitin Jain, MD, Marina Y. Konopleva, MD PhD, Jorge E. Cortes, MD, Farhad Ravandi, MD, Musa Yilmaz, MD

Blood (2018) 132 (Supplement 1): 4003.

https://doi.org/10.1182/blood-2018-99-118309

Published: 2018

Journal Articles

A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)

Ghaith Abu-Zeinah, MD, Mustafa Al-Kawaaz, MD, Valery J Li, MD, Yen-Michael S. Hsu, MD PhD, Melissa M. Cushing, MD, Joseph Scandura, MDPhD

Blood (2017) 130 (Supplement 1): 2409.

https://doi.org/10.1182/blood.V130.Suppl_1.2409.2409

Published: 2017

Journal Articles

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

M. Tayyeb Ayyoubi, MD, Suresh Manapuram, MD, Hamza Hashmi, MD, Katherine McDaniel, MLS (ASCP), Soumit K. Basu, MD PhD, William Tse, MD, Maxwell M. Krem, MD PhD

Blood (2017) 130 (Supplement 1): 4928.

https://doi.org/10.1182/blood.V130.Suppl_1.4928.4928

Published: 2017

Journal Articles

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Vamsi Kota, MBBS, Prachi Kharkhanis, Catherine R. Caprara, MSN, NP, Sheldon Bolds, Stephanie Debragga, Kathryn Sarah Simon, PA-C, Martha L. Arellano, MD, Anand Jillella, MD

Blood (2017) 130 (Supplement 1): 5017.

https://doi.org/10.1182/blood.V130.Suppl_1.5017.5017

Published: 2017

Journal Articles

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Lane Miller, MD, Sharon M. Castellino, MD MSc, Ann Mertens, PhD, Frank G Keller, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 2590.

https://doi.org/10.1182/blood.V130.Suppl_1.2590.2590

Published: 2017

Journal Articles

Daratumumab Is Safe and Highly Effective in AL Amyloidosis

Jack Khouri, MD, Thapa Bicky, MD, Frederic J. Reu, MD, Christy J. Samaras, DO, Hien D. Liu, MD, Mary Ann Karam, RN, Janice Reed, RN, Beth M. Faiman, PhDCNP, Jason Valent, MD

Blood (2017) 130 (Supplement 1): 1819.

https://doi.org/10.1182/blood.V130.Suppl_1.1819.1819

Published: 2017

Journal Articles

Patient Blood Management: An Initiative Aimed at Improving Outcomes While Decreasing Red Cell Transfusions with Specialty Guidelines for Hematology Patients

Christine Cahill, MS, BSN, RN, Neil Blumberg, MD, Amy E Schmidt, MDPhD, Scott Kirkley, MD, Majed A Refaai, MD

Blood (2017) 130 (Supplement 1): 3738.

https://doi.org/10.1182/blood.V130.Suppl_1.3738.3738

Published: 2017

Journal Articles

G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial

Anna B Halpern, MD, Emily M Huebner, Megan Othus, PhD, Bart L. Scott, MD, Pamela S. Becker, MD PhD, Mary-Elizabeth M. Percival, MD, Paul C. Hendrie, MD PhD, Kelda M Gardner, PA-C, Sarah A Buckley, MD, Elihu H. Estey, MD, Roland B. Walter, MD PhD

Blood (2017) 130 (Supplement 1): 149.

https://doi.org/10.1182/blood.V130.Suppl_1.149.149

Published: 2017

Journal Articles

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Azka Latif, MD, Vikas Kapoor, MD, Faisal Akbar, MD, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Hafiz Muhammad Fazeel, MD, Syeda Sabeeka Batool, MBBS, Zabih Warraich, MD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5411.

https://doi.org/10.1182/blood.V130.Suppl_1.5411.5411

Published: 2017

Journal Articles

Management of Coagulopathy Associated with CTL019 CAR T-Cell Therapy

Jochen Büchner, MDPhD, Stephan A Grupp, MD PhD, Shannon L Maude, MD PhD, Hidefumi Hiramatsu, MD PhD, David T Teachey, MD, Patricia A Wood, MD PhD, Rakesh Awasthi, PhD, Lan Yi, PhD, Barbara De Moerloose, MD PhD

Blood (2017) 130 (Supplement 1): 1276.

https://doi.org/10.1182/blood.V130.Suppl_1.1276.1276

Published: 2017

Journal Articles

Sanguinate: A Novel Blood Substitute Product

Trisha Plastini, DO, Patricia Locantore-Ford, MD, Heather Bergmann, MPH, BSN, RN

Blood (2017) 130 (Supplement 1): 1120.

https://doi.org/10.1182/blood.V130.Suppl_1.1120.1120

Published: 2017

Journal Articles

Transfusion Associated Circulatory Overload in Ambulatory Transfusions

Jock Simpson, FRACP, FRCPA, Adam Hopkins, Anoop Enjeti, MD FRCP, FRCPA, MClin Epid, GradCert Bioethics

Blood (2017) 130 (Supplement 1): 1124.

https://doi.org/10.1182/blood.V130.Suppl_1.1124.1124

Published: 2017

NARROW

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells

Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis

Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide

Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure

The High Output State of Sickle Cell Patients: Associations with Anemia-Related Organ Damage

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Long-Term Durable Responses after Autologous Stem Cell Transplantation in POEMS Syndrome

Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis

Weight Increase during Induction Therapy Predicts Intensive Care Unit (ICU) Transfer in Patients (Pts) with Acute Promyelocytic Leukemia (APL)

A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)

Use of a Hemoglobin Substitute (HBOC-201) to Treat Acute Anemia in a Leukemic Patient with Anti-Vel Antibodies

Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Daratumumab Is Safe and Highly Effective in AL Amyloidosis

Patient Blood Management: An Initiative Aimed at Improving Outcomes While Decreasing Red Cell Transfusions with Specialty Guidelines for Hematology Patients

G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Management of Coagulopathy Associated with CTL019 CAR T-Cell Therapy

Sanguinate: A Novel Blood Substitute Product

Transfusion Associated Circulatory Overload in Ambulatory Transfusions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only